View this email in your browser ([link removed])
** 3 November 2020
------------------------------------------------------------
** UK
------------------------------------------------------------
** BAT acquires Dryft nicotine pouches (#1)
------------------------------------------------------------
** International
------------------------------------------------------------
** VAPORESSO becomes one of the first CRC-compliant vaping brands in Canada (#2)
------------------------------------------------------------
** Study: Smoking has negative effects for patients with psoriasis (#3)
------------------------------------------------------------
** Parliamentary Activity
------------------------------------------------------------
** Parliamentary questions (#4)
------------------------------------------------------------
** UK
------------------------------------------------------------
**
------------------------------------------------------------
** British American Tobacco (BAT) on Tuesday 3 November, announced it has acquired the nicotine pouch business of US-based Dryft Sciences, expanding its range of oral nicotine products to 28 from four.
Financial terms of the deal were not disclosed, although BAT said the acquisition has no impact on its debt targets.
Source: Reuters, 3 November 2020
------------------------------------------------------------
Read Article ([link removed] )
** International
------------------------------------------------------------
**
------------------------------------------------------------
** VAPORESSO has become one of the first vaping companies to have passed the Child Resistant Certified (CRC) regulation introduced by the Canada Consumer Product Safety Act (CCPSA). CRC-compliance is a federal requirement for all vaping manufacturers who want to continue advertising and selling their vaping products in Canada. The regulation serves to prevent children and teenagers from using vaping products.
The company has taken action to implement child-proof designs on its vaping devices since 2018. VAPORESSO has said it aims to fully support the local policy of child protection against vaping products, focusing on optimising its products' child resistance.
------------------------------------------------------------
** Source: PR News Wire, 2 November 2020
------------------------------------------------------------
Read Article ([link removed] )
**
------------------------------------------------------------
** New research has found that smoking has adverse effects on patients with psoriasis, a skin disorder.
The researchers examined smoking behaviours of 133 patients with psoriasis and assessed the impact of smoking on disease characteristics. They found that of the psoriasis patients, 67.6% were smokers and that compared with non-smokers, smokers had higher frequencies of moderate-to-severe psoriasis, administration of systemic treatment, and cardiovascular disease. There was a positive correlation seen between the amount of smoking and psoriasis area and severity index.
The authors suggest that “supporting smoking cessation could make a contribution to the management of the negative effects of psoriasis.”
Source: Medical Xpress, 30 October 2020
See also: IJCP - Smoking Habits among Patients with Psoriasis and the Effect of Smoking on Clinical and Treatment‐associated Characteristics: A Cross Sectional Study ([link removed])
------------------------------------------------------------
Read Article ([link removed])
** Parliamentary Activity
------------------------------------------------------------
**
------------------------------------------------------------
** Electronic cigarettes: Health impacts and regulation – DHSC (Grouped questions)
Asked by Gareth Johnson Conservative, Dartford
To ask the Secretary of State for Health and Social Care, how many manufacturers, distributors and importers of e-cigarette products provided data on any adverse effects linked to their products, following the request for that data by the Medicines and Healthcare products Regulatory Agency in October 2019; and what proportion that accounted for of all notified e-cigarettes and refill containers.
Asked by Gareth Johnson Conservative, Dartford
To ask the Secretary of State for Health and Social Care, what enforcement action he has taken against (a) manufacturers, (b) distributors and (c) importers of e-cigarette products for alleged non-compliance with Article 39 vigilance requirements in the Tobacco and Related Products Regulations 2016 and non-reporting of adverse effects in relation to their products, since the October 2019 request by the Medicines and Healthcare products Regulatory Agency.
Asked by Gareth Johnson Conservative, Dartford
To ask the Secretary of State for Health and Social Care, what level of funding has been allocated to the Medicines and Healthcare products Regulatory Agency to support enforcement actions related to the Tobacco and Related Products Regulations in (a) 2018, (b) 2019 and (c) 2020.
Answered by Ms Nadine Dorries, Minister of State Department of Health and Social Care
In October 2019, in light of the emerging suspected cases of e-cigarette or vaping associated lung injury in the United States, the Medicines and Healthcare products Regulatory Agency (MHRA) requested data from 513 producers of nicotine containing e-liquid listed on the United Kingdom notified products list. The request was for information relating to any suspected respiratory adverse reaction in association with their products.
Overall, 275 responses were received, covering approximately 72% of notified products. Seventeen producers confirmed they had received reports and provided data. This resulted in the addition of 125 cases of adverse respiratory reactions to the MHRA database of suspected adverse reaction reports to e-cigarette products.
Source: Hansard, 2 November 2020
------------------------------------------------------------
Read Transcript ([link removed])
Have you been forwarded this email? Subscribe to ASH Daily News here. ([link removed])
For more information call 020 7404 0242, email
[email protected] (mailto:
[email protected]) or visit www.ash.org.uk
ASH Daily News is a digest of published news on smoking-related topics. ASH is not responsible for the content of external websites. ASH does not necessarily endorse the material contained in this bulletin.
============================================================
Our mailing address is:
Action on Smoking and Health
6th Floor New House
Hatton Garden
London
EC1N 8JY
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
